[go: up one dir, main page]

DK0674511T3 - Antipyretiske og analgetiske fremgangsmåder og midler indeholdende optisk rent R-ketorolac - Google Patents

Antipyretiske og analgetiske fremgangsmåder og midler indeholdende optisk rent R-ketorolac

Info

Publication number
DK0674511T3
DK0674511T3 DK94904855.7T DK94904855T DK0674511T3 DK 0674511 T3 DK0674511 T3 DK 0674511T3 DK 94904855 T DK94904855 T DK 94904855T DK 0674511 T3 DK0674511 T3 DK 0674511T3
Authority
DK
Denmark
Prior art keywords
ketorolac
pain
optically pure
antipyretic
agents containing
Prior art date
Application number
DK94904855.7T
Other languages
English (en)
Inventor
Stephen L Matson
Timothy J Barberich
Original Assignee
Sepracor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sepracor Inc filed Critical Sepracor Inc
Application granted granted Critical
Publication of DK0674511T3 publication Critical patent/DK0674511T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK94904855.7T 1992-12-17 1993-12-17 Antipyretiske og analgetiske fremgangsmåder og midler indeholdende optisk rent R-ketorolac DK0674511T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99198192A 1992-12-17 1992-12-17

Publications (1)

Publication Number Publication Date
DK0674511T3 true DK0674511T3 (da) 1997-04-21

Family

ID=25537797

Family Applications (1)

Application Number Title Priority Date Filing Date
DK94904855.7T DK0674511T3 (da) 1992-12-17 1993-12-17 Antipyretiske og analgetiske fremgangsmåder og midler indeholdende optisk rent R-ketorolac

Country Status (14)

Country Link
US (1) US5382591A (da)
EP (1) EP0674511B1 (da)
JP (1) JP2957701B2 (da)
KR (1) KR100264814B1 (da)
AT (1) ATE150969T1 (da)
AU (1) AU696620B2 (da)
CA (1) CA2151724C (da)
DE (1) DE69309492T2 (da)
DK (1) DK0674511T3 (da)
ES (1) ES2100046T3 (da)
FI (1) FI952985L (da)
GR (1) GR3023741T3 (da)
NO (1) NO307546B1 (da)
WO (1) WO1994013283A1 (da)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5464609A (en) * 1990-03-16 1995-11-07 The Procter & Gamble Company Use of ketorolac for treatment of oral diseases and conditions
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac
US5955504A (en) * 1995-03-13 1999-09-21 Loma Linda University Medical Center Colorectal chemoprotective composition and method of preventing colorectal cancer
US6160018A (en) * 1995-03-13 2000-12-12 Loma Linda University Medical Center Prophylactic composition and method for alzheimer's Disease
US5981592A (en) * 1995-03-13 1999-11-09 Loma Linda University Medical Center Method and composition for treating cystic fibrosis
DE69841267D1 (de) * 1997-03-10 2009-12-10 Univ Loma Linda Med Verwendung von r-carprofen zur Vorbeugung der Alzheimerschen Krankheit
US6451806B2 (en) 1999-09-29 2002-09-17 Adolor Corporation Methods and compositions involving opioids and antagonists thereof
US6576191B1 (en) * 1999-09-30 2003-06-10 Therox, Inc. Apparatus for blood oxygenation
US6469030B2 (en) 1999-11-29 2002-10-22 Adolor Corporation Methods for the treatment and prevention of ileus
AU5702201A (en) * 2000-04-13 2001-10-30 Mayo Foundation Abeta<sub>42</sub> lowering agents
US20030027867A1 (en) * 2001-06-29 2003-02-06 Myriad Genetics, Incorporated Use of R-NSAID compounds for anti-HIV treatment
WO2003068159A2 (en) * 2002-02-11 2003-08-21 Wake Forest University Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
EP1603548A4 (en) * 2003-02-05 2007-10-10 Myriad Genetics Inc METHOD AND COMPOSITION FOR THE TREATMENT OF NEURODEEGENERATIVE DISEASES
US20050042284A1 (en) * 2003-07-11 2005-02-24 Myriad Genetics, Incorporated Pharmaceutical methods, dosing regimes and dosage forms for the treatment of Alzheimer's disease
DK1654002T4 (da) 2003-08-07 2014-02-17 Allergan Inc Sammensætninger til fremføring af terapeutiske midler til øjnene
WO2006001877A2 (en) * 2004-04-13 2006-01-05 Myriad Genetics, Inc. Combination treatment for neurodegenerative disorders comprising r-flurbiprofen
EP1745180A1 (en) * 2004-04-29 2007-01-24 Keystone Retaining Wall Systems, Inc. Veneers for walls, retaining walls and the like
WO2006020850A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
CA2618985A1 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
WO2006020852A2 (en) * 2004-08-11 2006-02-23 Myriad Genetics, Inc. Pharmaceutical composition and method for treating neurodegenerative disorders
US20070042034A1 (en) * 2005-07-22 2007-02-22 Myriad Genetics, Incorporated High drug load formulations and dosage forms
US20080033045A1 (en) * 2006-07-07 2008-02-07 Myriad Genetics, Incorporated Treatment of psychiatric disorders
US7842714B2 (en) * 2008-03-03 2010-11-30 Allergan, Inc. Ketorolac tromethamine compositions for treating ocular pain
US9192571B2 (en) * 2008-03-03 2015-11-24 Allergan, Inc. Ketorolac tromethamine compositions for treating or preventing ocular pain
MX2008003230A (es) * 2008-03-07 2009-09-07 Senosiain S A De C V Lab Composicion famaceutica oral que comprende la combinacion de una sal de ketorolaco y vitaminas del complejo b.
CN112094271B (zh) * 2019-06-18 2023-03-21 鲁南制药集团股份有限公司 一种酮咯酸晶型及其制备方法
CN110540542A (zh) * 2019-09-12 2019-12-06 南京海融制药有限公司 一种苯乙酸类化合物的钠盐、结晶形式及其制备方法
EP4110329A4 (en) * 2020-02-24 2024-04-10 Yinuoke Medicine Science Technology Company Ltd. COMPOSITIONS AND METHODS FOR TREATING CYTOKINE STORM AND CYTOKINE RELEASE SYNDROME
CN114276350B (zh) * 2020-09-28 2023-05-16 鲁南制药集团股份有限公司 一种酮咯酸与吩嗪共晶及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4089969A (en) * 1976-07-14 1978-05-16 Syntex (U.S.A.) Inc. 5-Aroyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid derivatives and process for the production thereof
WO1987006266A1 (en) * 1986-04-16 1987-10-22 Wisconsin Alumni Research Foundation ENZYMATIC PROCESS FOR PREPARING OPTICALLY-ACTIVE 1,2-DIHYDRO-3H-PYRROLO[1,2a]PYRROLE-1-CARBOXYLIC ACID DERIVATIVES
BR9106166A (pt) * 1990-03-16 1993-03-16 Procter & Gamble Uso de cetorolac para o tratamento de doenca periodontal
JP3541849B2 (ja) * 1991-04-19 2004-07-14 久光製薬株式会社 消炎鎮痛貼付剤
US5382591A (en) * 1992-12-17 1995-01-17 Sepracor Inc. Antipyretic and analgesic methods using optically pure R-ketorolac

Also Published As

Publication number Publication date
AU5872194A (en) 1994-07-04
NO952418L (no) 1995-08-03
JP2957701B2 (ja) 1999-10-06
DE69309492T2 (de) 1997-07-10
KR100264814B1 (ko) 2000-09-01
US5382591A (en) 1995-01-17
FI952985A7 (fi) 1995-08-16
FI952985L (fi) 1995-08-16
JPH08505133A (ja) 1996-06-04
ES2100046T3 (es) 1997-06-01
DE69309492D1 (de) 1997-05-07
GR3023741T3 (en) 1997-09-30
NO307546B1 (no) 2000-04-25
EP0674511A1 (en) 1995-10-04
CA2151724A1 (en) 1994-06-23
EP0674511B1 (en) 1997-04-02
CA2151724C (en) 2000-10-31
KR950703951A (ko) 1995-11-17
NO952418D0 (no) 1995-06-16
AU696620B2 (en) 1998-09-17
ATE150969T1 (de) 1997-04-15
FI952985A0 (fi) 1995-06-16
WO1994013283A1 (en) 1994-06-23

Similar Documents

Publication Publication Date Title
DK0674511T3 (da) Antipyretiske og analgetiske fremgangsmåder og midler indeholdende optisk rent R-ketorolac
DK0727994T3 (da) Anvendelse af antipyretiske og analgetiske præparater indeholdende optisk rent R-etodolac
RU94042899A (ru) Способ достижения болеутоляющего эффекта, способ лечения и профилактики гипертермии у человека, болеутоляющая и жаропонижающая композиции, содержащие оптически чистый r (-) кетопрофен
DK0513702T3 (da) Melatoninderivater til anvendelse til behandling af søvnlidelser og til præ-anæstetisk medicinering
DE68919358D1 (de) Zusammensetzung zur behandlung der schizophrenie.
TR199801180T2 (xx) Aneljestik etkiye sahip yeni bile�ikler.
DK0719154T3 (da) Aktiveret faktor VIII som terapeutisk middel og metode til behandling af faktor VIII-mangel
GEP20053720B (en) Triamide-Substituted Indoles, Benzofuranes and Benzothiophenes as Inhibitors of Microsomal Triglyceride Transfer Protein (MTP) and/or Apolipoprotein B (Apo B) Secretion
NO960067L (no) Nytt farmasöytisk preparat
DK0806948T3 (da) Behandling af urininkontinens ved anvendelse af (S)-oxybutynin og (S)-desethyloxybutynin
DK0723444T3 (da) Levobupivacain, som er egnet til behandling af kronisk smerte
HUP9904360A2 (hu) Eljárás emesis és központi idegrendszeri rendellenességek kezelésére, optikailag tiszta (+)-norciszaprid alkalmazásával
ATE189601T1 (de) Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen
HUP0000873A2 (hu) A levobupivakain arcsebészeti alkalmazása
DK0687184T3 (da) Rekombinante adenoviruser og anvendelse deraf ved genterapi til behandling af øjensygdomme
DE69800859D1 (de) Verwendung von Moxonidin zur Behandlung neuropathischer Schmerzen
DK0579488T3 (da) Præparat til behandling af mastitis og matritis
ATE145825T1 (de) Behandlung von erhöhtem blutdruck
GB9419318D0 (en) Therapeutic agents
DK0769945T3 (da) Brug af 2-phenyl-3-aroylbenzothiophenderivater til fremstilling af et medikament til behandling af knogler og knoglebrud
PT98764A (pt) Processo para a preparacao de composicoes contendo factor de desenvolvimento de insulina 1 completo para o tratamento terapeutico ou profilactico de estado catabolicos
NO961180L (no) Transdermal anordning inneholdende (E)-2-(p-fluorfenetyl)-3-fluorallylamin for behandling av Alzheimers sykdom
MD1469G2 (ro) Metodă de tratament al şocului combustional
RU93027489A (ru) Способ хирургической коррекции хронических нарушений дуоденальной проходимости